Munafa Stock Market Course + Intraday & FNO calls 
GLENMARK NEWS why is Glenmark Pharmaceuticals Limited price falling or rising
GLENMARK NEWS reasons for why stock price of Glenmark Pharmaceuticals Limited is falling or rising
GLENMARK Glenmark Pharmaceuticals is falling or rising technical reasons
Technical analysis forecast of Glenmark Pharmaceuticals Stock is that its in a uptrend for shortterm, and I will avoid taking a SHORT or SELL trade in this stock. Look for opportunities to BUY or go LONG in Glenmark Pharmaceuticals GLENMARK at this time. Stock is rising and might rise more.
It appears as if Glenmark Pharmaceuticals GLENMARK gave a large move recently.
Stock of Glenmark Pharmaceuticals (GLENMARK) is trading above an important moving average line, and it has been above this line for quite some time now. This is a good sign, and the stock might keep rising and move higher!
My analysis of Glenmark Pharmaceuticals is bullish for shortterm, but stock is in semi over bought zones and there are some chances of seeing a fall tomorrow. Use 2200 as stoploss in an intra day sell trade for a target of 2124.22. However, stock will show a bullish move above 2200.
GLENMARK Glenmark Pharmaceuticals is falling or rising NEWS fundamental reasons
Company Announcement Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 16, 2026, titled "Glenmark Pharmaceuticals Inc., USA to launch - NEWS as on 2026-03-16
Company Announcement Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 04, 2026, titled "Glenmark Specialty SA Receives U.S. FDA Approval for Fluticasone Propionate Inhalation Aerosol USP, 44 mcg per actuation, with 180-Day Compet - NEWS as on 2026-03-04
Glenmark Pharmaceuticals wins USFDA nod for fluticasone inhaler Glenmark Pharmaceuticals has secured a significant approval from the US FDA for its inhaler fluticasone propionate. This marks a key step in strengthening the company's respiratory offerings in the US market. The product is set for distribution starting Ma - NEWS as on 2026-03-04 indiatimes.com
Glenmark set to join peers in 'Semaglutide' push Glenmark Pharmaceuticals is set to launch affordable versions of the popular anti-diabetes and obesity drug semaglutide. This move escalates competition in a rapidly growing market. The Indian patent for semaglutide expires soon, allowing multiple local dr - NEWS as on 2026-03-02 indiatimes.com
Company Announcement Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 27, 2026, titled "Glenmark Pharmaceuticals Inc., USA to launch Sodium Phosphates Injection USP, - NEWS as on 2026-02-27
Company Announcement Glenmark Pharmaceuticals Limited has informed the Exchange about ESG Rating. - NEWS as on 2026-02-23
Company Announcement Glenmark Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication - NEWS as on 2026-02-18
Company Announcement Glenmark Pharmaceuticals Limited has informed the Exchange about Transcript - NEWS as on 2026-02-04
Company Announcement Glenmark Pharmaceuticals Limited has informed the Exchange about Schedule of meet - NEWS as on 2026-02-03
Company Announcement Glenmark Pharmaceuticals Limited has informed the Exchange about Link of Recording - NEWS as on 2026-02-02
Company Announcement Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory action/ inspection - NEWS as on 2026-02-01
Company Announcement Glenmark Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 - NEWS as on 2026-01-20
More announcements and NEWS
GLENMARK Glenmark Pharmaceuticals Limited current price & indicator signals
Recent prices of GLENMARK Glenmark Pharmaceuticals Limited are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 16 Mon Mar 2026 | 2175.40 | 2145.00 to 2214.80 | 0.22% | 0.8 times |
| 13 Fri Mar 2026 | 2170.70 | 2163.70 to 2266.00 | -3.8% | 0.78 times |
| 12 Thu Mar 2026 | 2256.40 | 2215.40 to 2273.20 | -0.72% | 1.51 times |
| 11 Wed Mar 2026 | 2272.70 | 2228.00 to 2297.90 | 2.11% | 1.4 times |
| 10 Tue Mar 2026 | 2225.80 | 2130.40 to 2240.00 | 5.11% | 2.36 times |
| 09 Mon Mar 2026 | 2117.60 | 2050.20 to 2124.80 | -0.32% | 0.46 times |
| 06 Fri Mar 2026 | 2124.40 | 2094.40 to 2138.00 | 0.73% | 0.65 times |
| 05 Thu Mar 2026 | 2108.90 | 2042.20 to 2118.90 | 3.39% | 0.79 times |
| 04 Wed Mar 2026 | 2039.70 | 2031.10 to 2110.50 | -3.94% | 0.63 times |
| 02 Mon Mar 2026 | 2123.30 | 2094.40 to 2149.90 | -0.63% | 0.48 times |
| 27 Fri Feb 2026 | 2136.70 | 2116.40 to 2159.80 | 0.58% | 0.93 times |
| 26 Thu Feb 2026 | 2124.30 | 2080.00 to 2139.00 | 1.88% | 0.78 times |
Videos related to: GLENMARK NEWS why is Glenmark Pharmaceuticals Limited price falling or rising
Hindi Basics How To Trade In FnO Futures Options Stock Market
- NSE Screeners
- NSE Daily Screener
- NSE Weekly Screener
- NSE Monthly Screener
- Support & Resistance
- NSE Shares Near Support
- NSE Shares Near Resistance
